| Ruxton Orthotics & Medical Supplies | |
| 201 Plumtree Rd, Ste 301, Bel Air, Maryland 21015 | |
| (410) 616-1420 |
| Name | Ruxton Orthotics & Medical Supplies |
|---|---|
| Organization Name | University Of Maryland St. Joseph Orthopaedics, Llc |
| Location | 201 Plumtree Rd, Ste 301, Bel Air, Maryland 21015 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (410) 616-1420 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the publication of key preclinical data demonstrating that inhibition of the Transient Receptor Potential Vanilloid (TRPV) family of ion channels - specifically TRPV4 - resulted in activation of brown/beige fat and protection from diet-induced obesity, inflammation and insulin resistance. Ember holds an exclusive option to license these TRPV4 findings and technology.
University of Alberta scientists have identified a receptor in cells that could be key to preventing permanent hearing loss in childhood cancer survivors who are being treated with the drug cisplatin.
A study led by UT Southwestern and Children's Health researchers defines parameters for the number of white blood cells that must be present in children's urine at different concentrations to suggest a urinary tract infection (UTI).
Peregrine Pharmaceuticals, Inc. today reported completion of patient enrollment in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in advanced breast cancer patients.
› Verified 7 days ago
| NPI Number | 1629621222 |
| Organization Name | UNIVERSITY OF MARYLAND ST. JOSEPH ORTHOPAEDICS, LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 201 Plumtree Rd Ste 301, Bel Air, MD 21015 |
| Phone Number | 410-569-3326 |
News Archive
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the publication of key preclinical data demonstrating that inhibition of the Transient Receptor Potential Vanilloid (TRPV) family of ion channels - specifically TRPV4 - resulted in activation of brown/beige fat and protection from diet-induced obesity, inflammation and insulin resistance. Ember holds an exclusive option to license these TRPV4 findings and technology.
University of Alberta scientists have identified a receptor in cells that could be key to preventing permanent hearing loss in childhood cancer survivors who are being treated with the drug cisplatin.
A study led by UT Southwestern and Children's Health researchers defines parameters for the number of white blood cells that must be present in children's urine at different concentrations to suggest a urinary tract infection (UTI).
Peregrine Pharmaceuticals, Inc. today reported completion of patient enrollment in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in advanced breast cancer patients.
› Verified 7 days ago
News Archive
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the publication of key preclinical data demonstrating that inhibition of the Transient Receptor Potential Vanilloid (TRPV) family of ion channels - specifically TRPV4 - resulted in activation of brown/beige fat and protection from diet-induced obesity, inflammation and insulin resistance. Ember holds an exclusive option to license these TRPV4 findings and technology.
University of Alberta scientists have identified a receptor in cells that could be key to preventing permanent hearing loss in childhood cancer survivors who are being treated with the drug cisplatin.
A study led by UT Southwestern and Children's Health researchers defines parameters for the number of white blood cells that must be present in children's urine at different concentrations to suggest a urinary tract infection (UTI).
Peregrine Pharmaceuticals, Inc. today reported completion of patient enrollment in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in advanced breast cancer patients.
› Verified 7 days ago
Rite Aid Pharmacy 11208 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5 Bel Air S Pkwy, Bel Air, Maryland 21015 Phone: (410) 569-0833 | |
Cvs Pharmacy #02499 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1221 E Churchville Rd, Bel Air, Maryland 21014 Phone: (410) 420-8319 | |
Cvs Pharmacy #16391 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 580 Marketplace Dr, Bel Air, Maryland 21014 Phone: (410) 638-9031 | |
Redner's Pharmacy #35 Type: Community/Retail Pharmacy Location: 2126 N Fountain Green Rd, Bel Air, Maryland 21015 Phone: (410) 838-7694 | |
Kleins Pharmacy At Festival Type: Community/Retail Pharmacy Location: 5 Bel Air South Pkwy, Bel Air, Maryland 21015 Phone: (443) 512-8373 |